Considering that Tumor Immune Dysfunction and Exclusion (TIDE) scores serve as indicators of sensitivity to immune checkpoint inhibitors, an evaluation of disparities in TIDE scores between the PGC1α high expression and low expression groups within the TCGA-COAD/READ dataset ensued. Here, PPARGC1A is linked to neoplasm.